Treatment of Congenital Heart Disease at Clínic

Reading time: 2 min

Adult patients with congenital heart disease are a growing population due to progress and constant improvement in treatments performed in children. They represent a very diverse population that frequently presents a very high complexity and requires very complex interventions.

The Hospital Clínic has extensive experience in this field and offers patients a global approach that covers all available diagnostic and therapeutic possibilities, with the utmost rigor and with a large group of highly specialized professionals in all aspects of the disease and your treatment.

The patient with congenital heart disease has had a growing trend and has gone from a total of 149 visits in 2011 to 481 in 2017.

Currently, some 50-70 surgical interventions are performed on congenital adult patients, with a mortality of 0% from 2013-2018. Adult surgeries for Ebstein and Fontan repair, aortic valve repair, atrioventricular canal repair, and anomalous coronary births are on the increase and with excellent results. In several cases, minimally invasive surgery is performed without requiring a thoracotomy, less scarring and faster recovery. In addition, cardiac rehabilitation is available prior to and during admission.

At the level of hemodynamics, very diverse procedures are performed. Among the most frequent are stents for coarctation of the aorta, percutaneous pulmonary prostheses, closure of atrial septal defect, stents in pulmonary arteries, closure of fistulas and mitral valvuloplasty.

The Hospital Clínic is CSUR (Reference Centers, Services and Units) in congenital heart disease in adults since 2016.

Professionals actively participate in Congresses and in various research studies. There is also a constant relationship with patient associations (AACIC, corAvant) and collaboration with the 'Festes del Cor' in the Tibidabo Amusement Park and in Portaventura.

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.